Pediatric Hypercalciuria Treatment & Management
- Author: Sahar Fathallah-Shaykh, MD; Chief Editor: Craig B Langman, MD more...
Medical Care
The goals of therapy in children with hypercalciuria should be the elimination of symptoms, prevention of renal stone formation, and preservation of kidney function.
Dietary modification is a mandatory part of effective therapy. The child should be referred to a dietitian to accurately assess daily calcium, animal protein, and sodium intake. As previously mentioned, a trial of a low-calcium diet can be done transiently to determine if exogenous calcium intake is contributing to the high urinary calcium. However, great caution should be used when trying to restrict calcium intake for long periods.
Because of the concern regarding poor bone matrix calcification and subsequent osteoporosis, no child should receive less than the daily recommended intake (DRI) of calcium for long periods without careful monitoring. If the dietary calcium is restricted to less than the DRI, bone density measurements and growth parameters should be taken at regular intervals to monitor the development of osteoporosis and growth retardation. Reducing sodium and animal protein to the DRI may facilitate lowering of urinary calcium. However, the authors recommend that great caution be used when placing any child on a diet with less than the DRI of calcium and that a dietitian be consulted for assistance. If this does not provide the desired results of symptom relief, prevention of nephrolithiasis, and normalization of calcium excretion (< 4 mg/kg/d), pharmacotherapy should be initiated.
Another indication for starting medication is evidence of bone demineralization or history of previous renal stone formation despite a low calcium diet. Hydrochlorothiazide (HCTZ) and other thiazide-type diuretics are the agents most frequently used to treat hypercalciuria. These agents are discussed further in the Medication section.
Lithotripsy may be needed to remove a urinary stone that is not spontaneously passed and is associated with urinary obstruction.
Reduction of dietary calcium lowers urinary calcium but may increase urinary oxylate. The new calcium-oxylate product may result in supersaturation.
Surgical Care
Surgical care is not usually necessary in children with hypercalciuria unless an underlying urological abnormality is present that predisposes a child to develop renal stones. Rarely, sonographic techniques are insufficient to remove a renal stone, and surgery is needed to relieve an obstruction.
Consultations
A pediatric nephrologist should evaluate and treat any child with proven or suspected hypercalciuria. Once hypercalciuria is diagnosed, a pediatric dietitian should be consulted to help construct an appropriate diet. In cases where urological abnormalities are detected or renal stones form without prompt spontaneous passage, a pediatric urologist should be involved in caring for the child.
Diet
Dietary modifications are important components in treating children with hypercalciuria. General guidelines that are applicable to most children with hypercalciuria include the following:
- Maintain water intake at 1500 mL/m2/d.
- Restrict dietary calcium to the DRI for age. The US Food and Drug Administration (FDA) sets the DRI (or recommended daily allowance [RDA]) by doubling the estimated daily need. This was done to ensure an adequate amount of calcium (and other vitamins and minerals) intake for growth and development.
- Some people believe that this is an overestimation of the amount of calcium intake actually needed. In otherwise healthy children with normal urinary calcium excretion, the excess calcium is removed in the urine without consequence. However, in children who have hypercalciuria, this amount of dietary calcium may induce symptoms or renal stone formation.
- Consequently, some health care providers believe it may be safe to use less than the DRI of calcium in children who are still having hypercalciuria and renal stone formation with normal amounts of calcium in their diet. If such a diet is used, monitoring bone mineralization and growth parameters at regular intervals is essential. Alternatively, if the desired urinary calcium excretion is not achieved with the RDI of calcium, pharmacotherapy can be initiated.
- Restricting dietary sodium may also be helpful in children with hypercalciuria. As mentioned above, a direct relationship between sodium chloride intake and urinary calcium excretion is observed. Therefore, limiting salt intake should help reduce the amount of urinary calcium. No data indicate that high salt intake alone can induce the clinical syndrome of hypercalciuria. However, evidence may show that lower sodium diets help reduce urinary calcium excretion in children who have idiopathic hypercalciuria. A good target range for dietary sodium intake is 2-3 mEq/kg/d.
- In children with a history of calcium oxalate stones, lowering dietary oxalate is indicated.
- Diets high in animal protein may produce a larger metabolic acid load in adults and contribute to stone formation. Studies in children are not available; however, protein intakes higher than the DRI are not necessary and may be harmful.
Activity
No limitations of activity are needed, but an effort should be made to ensure adequate fluid intake with increased insensible losses (eg, exercise).
Srivastava T, Alon US. Pathophysiology of hypercalciuria in children. Pediatr Nephrol. Oct 2007;22(10):1659-73. [Medline].
Worcester EM, Coe FL. New insights into the pathogenesis of idiopathic hypercalciuria. Semin Nephrol. Mar 2008;28(2):120-32. [Medline].
Duffey BG, Pedro RN, Kriedberg C, Weiland D, Melquist J, Ikramuddin S, et al. Lithogenic risk factors in the morbidly obese population. J Urol. Apr 2008;179(4):1401-6. [Medline].
Ayoob R, Wang W, Schwaderer A. Body fat composition and occurrence of kidney stones in hypercalciuric children. Pediatr Nephrol. Jun 10 2011;[Medline].
Escribano J, Balaguer A, Martin R. Childhood idiopathic hypercalciuria--clinical significance of renal calyceal microlithiasis and risk of calcium nephrolithiasis. Scand J Urol Nephrol. 2004;38(5):422-6. [Medline].
Zerwekh JE. Bone disease and hypercalciuria in children. Pediatr Nephrol. Mar 2010;25(3):395-401. [Medline].
Alon US, Berenbom A. Idiopathic hypercalciuria of childhood: 4- to 11-year outcome. Pediatr Nephrol. Sep 2000;14(10-11):1011-5. [Medline].
Barratt TM, Duffy PG. Nephrocalcinosis and urolithiasis. Pediatr Nephrol. 1999;1:933-45.
Biyikli NK, Alpay H, Guran T. Hypercalciuria and recurrent urinary tract infections: incidence and symptoms in children over 5 years of age. Pediatr Nephrol. 2005;20(10):1435-8. [Medline].
Borghi L, Schianchi T, Meschi T, et al. Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med. Jan 10 2002;346(2):77-84. [Medline].
Burren CP, Curley A, Christie P, et al. A family with autosomal dominant hypocalcaemia with hypercalciuria (ADHH): mutational analysis, phenotypic variability and treatment challenges. J Pediatr Endocrinol Metab. 2005;18(7):689-99. [Medline].
Gonzalez C, Ariceta G, Langman CB, Zibaoui P, Escalona L, Dominguez LF, et al. Hypercalciuria is the main renal abnormality finding in Human Immunodeficiency Virus-infected children in Venezuela. Eur J Pediatr. May 2008;167(5):509-15. [Medline].
Heiliczer JD, Canonigo BB, Bishof NA, Moore ES. Noncalculi urinary tract disorders secondary to idiopathic hypercalciuria in children. Pediatr Clin North Am. Jun 1987;34(3):711-8. [Medline].
Kang JH, Choi HJ, Cho HY, et al. Familial hypomagnesemia with hypercalciuria and nephrocalcinosis associated with CLDN16 mutations. Pediatr Nephrol. 2005;20(10):1490-3. [Medline].
Polinsky MS, Kaiser BA, Baluarte HJ, Gruskin AB. Renal stones and hypercalciuria. Adv Pediatr. 1993;40:353-84. [Medline].
Polito C, La Manna A, Cioce F. Clinical presentation and natural course of idiopathic hypercalciuria in children. Pediatr Nephrol. Dec 2000;15(3-4):211-4. [Medline].
Richmond W, Colgan G, Simon S, et al. Random urine calcium/osmolality in the assessment of calciuria in children with decreased muscle mass. Clin Nephrol. 2005;64(4):264-70. [Medline].

